Poster session 7: Ataxia, chorea, drug‐induced movement disorders, myoclonus, spasticity, stereotypies, tics, tremor

Identifieur interne : 008424 ( Main/Exploration ); précédent : 008423; suivant : 008425

---

Poster session 7: Ataxia, chorea, drug‐induced movement disorders, myoclonus, spasticity, stereotypies, tics, tremor

Auteurs :

Source :

• Movement Disorders [ 0885-3185 ] ; 2002-11.

RBID : ISTEX:62F90CE7D724C99CA696F9CEF306833784E60804

Descripteurs français

• Wicri :
  • topic : Glucose, Neurologie, Traumatisme.

English descriptors

• KwdEn :
  • Abnormal, Abnormal movements, Abnormality, Accelerometric, Accelerometry, Action tremor, Adhd, Adult onset, Adverse events, Agonist, Algorithm, Allele, Anticholinergic, Antidepressant, Antioxidant, Antipsychotic, Arotinolol, Ashworth, Ashworth scale, Asymptomatic, Ataxia, Ataxic, Ataxic gait, Ataxic syndrome, Atrophy, Attention hyperactivity disorder, Atypical, Autosomal, Baclofen, Basal, Basal ganglia, Baseline, Benign, Bilateral, Bilaterally, Bipolar, Bipolar disorder, Bipolar studies, Blood concentration, Blood glucose, Botulinum, Botulinum toxin, Bradykinesia, Brainstem, Bupropion, Case report, Case reports, Caudate, Caudate nucleus, Caudate nucleus atrophy, Cdas, Cell models, Cerebellar, Cerebellar ataxia, Cerebellar atrophy, Cerebellum, Cerebral palsy, Cervical, Chain activity, Chorea, Choreatic movements, Choreic, Choreic movements, Choreiform, Choreiform movements, Chromosome, Chronic haloperidol, Chronic treatment, Clinic, Clinical, Clinical assessment, Clinical characteristics, Clinical diagnosis, Clinical features, Clinical improvement, Clinical presentation, Clinical presentations, Clinical progression, Clinical scores, Clinical spectrum, Clinical symptoms, Clonazepam, Clozapine, Cognitive, Cognitive disturbances, Cognitive dysfunction, Cognitive impairment, Coherence, Coherence analysis, Cohort, Coli, Comorbid, Comorbid symptoms, Compulsive disorder, Compulsive symptoms, Computerized tremor analysis, Concordance, Consecutive patients, Contralateral, Control group, Control groups, Control subjects, Cortical, Cortical myoclonus, Cortical tremor, Creatine, Crossover, Cyclooxygenase, Cyclooxygenase inhibitors, Deep tendon, Dementia, Diagnosis criteria, Diagnostic accuracy, Diagnostic criteria, Differential diagnosis, Disability, Disease duration, Disease duration years, Disease onset, Disease progression, Disease rating scale, Disease stage, Disorder, Dopamine, Dopaminergic, Dorsal, Dos, Dose, Drinking task, Drinking tremor, Drug intake, Dysarthria, Dysfunction, Dyskinesia, Dysmetria, Dystonia, Dystonic, Eds, Effective treatment, Electrical injury, Electromyography, Electrophysiological, Electrophysiological characteristics, Encephalopathy, Energy metabolism, Enhancement, Environmental factors, Epilepsia partialis continua, Epilepsy, Essential tremor, Etiology, Exam, Exor, Explosive outbursts, Extrapyramidal, Extrapyramidal symptoms, Facilitation, Familial, Familial cases, Family history, Frda, Functional disability, Further study, Gait, Gait analysis, Gait ataxia, Gait disturbance, Gait parameters, Ganglion, Gender, Gene, Genetic, Genetic analysis, Genetic factors, Genetic heterogeneity, Genetic testing, Globus, Globus pallidus, Glucose, Glutamate, Glutathione levels, Gluten, Gluten sensitivity, Graft, Gravitational acceleration, Haloperidol, Hand tremor, Harmane, Head tremor, Healthy controls, Healthy subjects, Hemichorea, Hemifacial spasm, Hereditary, Hereditary ataxias, Heterogeneous disorder, Heterogeneous group, Huntingtin, Hyperactivity, Hyperglycemia, Hyperintense, Hypometabolic voxels, Icars, Icars scores, Idiopathic, Imaging, Impairment, Implantation, Important role, Infarction, Inhibitor, Intention tremor, Interim analysis, International congress, Intrathecal, Intrathecal baclofen, Intrathecal baclofen therapy, Involuntary, Involuntary movements, Ipsilateral thalamic infarction, Ischemic, Jerk, Kinetic components, Latency, Lesion, Levetiracetam, Levodopa, Limb, Limb myoclonus, Linkage analysis, Lipid peroxidation, Locus, Lower doses, Lower limbs, Lumbar puncture, Magnetic resonance spectroscopy, Major depression, Male patient, Male patients, Matter changes, Median, Medication, Metabolism, Methamphetamine, Methylphenidate, Mirtazapine, Mitochondrial, Mitochondrial dysfunction, Monoclonal gammopathy, More subjects, Motor cortex, Motor effects, Motor performance, Motor score, Motor tics, Mouse model, Movement disorder, Movement disorders, Movement disorders clinic, Movement duration, Multiple motor, Multiple sclerosis, Muscle strength, Mutant, Mutant huntingtin, Mutation, Myoclonic, Myoclonic dystonia, Myoclonic jerks, Myoclonus, Nding, Ndings, Ndings support, Negative correlation, Neural network, Neurodegenerative, Neuroimaging, Neuroimaging studies, Neurol, Neuroleptic, Neurologic, Neurological, Neurological examination, Neurologist, Neurology, Neuron, Neuronal, Neuropathy, Neurophysiological, Neurophysiological examination, Neuropsychological, Neuropsychological testing, Neuropsychological tests, Nger, Nger test, Normal controls, Normal subjects, November, Nystagmus, Obsessive, Ocular, Ocular motor apraxia, Olanzapine, Olanzapine treatment, Older patients, Olmsted county, Open label, Opioid, Orobuccal dyskinesia, Orofacial, Orofacial dyskinesia, Orofacial dyskinesias, Orthostatic, Orthostatic tremor, Other medications, Other movement disorders, Other patients, Other signs, Oxidative, Oxidative stress, Palatal, Palatal tremor, Palsy, Paraneoplastic, Paraneoplastic syndrome, Parkinsonian, Parkinsonian patients, Parkinsonism, Pathogenesis, Pathophysiology, Pathway, Patient, Patient effort, Peripheral neuropathy, Peripheral origin, Pharmacological, Pharmacological treatment, Phenotype, Phonic, Phonic tics, Physiologic tremor, Piracetam, Placebo, Positive family history, Poster, Poster session, Postural, Postural conditions, Postural tremor, Premonitory, Premonitory sensation, Premonitory sensations, Present case, Present study, Prevalence, Previous reports, Previous studies, Primary orthostatic tremor, Progression, Progressive ataxia, Propranolol, Propriospinal, Propriospinal myoclonus, Pshd patients, Psychogenic, Putamen, Quantitative method, Quercetin, Randomized, Range years, Rating, Rating scale, Receptor, Receptor dysfunction, Refractory, Rest tremor, Restless legs syndrome, Retrospective chart review, Reversible chorea, Right putamen, Riluzole, Sarcoglycan gene, Sarizotan, Sca2, Sca2 patients, Schizophrenia, Sclerosis, Sensorimotor, Serotonin, Severe spasticity, Severe tremor, Severity, Severity scale, Sgce, Side effects, Single doses, Skeletal muscle, Spastic, Spastic hemiplegic patients, Spastic patients, Spastic side, Spasticity, Spect, Spectral analysis, Spinal, Spinal myoclonus, Spinocerebellar, Spirograph, Sporadic cases, Ssri, Statistical analysis, Stereotyped movement disorder, Stimulation, Striatal, Striatum, Study group, Study period, Subacute, Suppl, Symptom, Symptomatic palatal tremor, Synaptic, Syndrome, Tardive, Tardive dyskinesia, Test stimulation, Thalamic, Thalamus, Tic, Time points, Tizanidine, Tolerability, Tongue protrusions, Topiramate, Total power, Tourette, Tourette syndrome, Toxin, Tracer uptake, Transgenic mice, Trauma, Treatment periods, Treatment response, Tremor, Tremor accelerometry, Tremor amplitude, Tremor disability, Tremor disability scale, Tremor frequencies, Tremor frequency, Tremor rating scale, Tremor severity, Twin pairs, Uhdrs, Unclear, Upper limb, Useful tool, Utter syndrome, Valproic acid, Variability, Vocal tics, Voice tremor, Voluntary control, Voluntary motor function, Wide range, Wilcoxon test, Younger patients, Ziprasidone.
• Teeft :
  • Abnormal, Abnormal movements, Abnormality, Accelerometric, Accelerometry, Action tremor, Adhd, Adult onset, Adverse events, Agonist, Algorithm, Allele, Anticholinergic, Antidepressant, Antioxidant, Antipsychotic, Arotinolol, Ashworth, Ashworth scale, Asymptomatic, Ataxia, Ataxic, Ataxic gait, Ataxic syndrome, Atrophy, Attention hyperactivity disorder, Atypical, Autosomal, Baclofen, Basal, Basal ganglia, Baseline, Benign, Bilateral, Bilaterally, Bipolar, Bipolar disorder, Bipolar studies, Blood concentration, Blood glucose, Botulinum, Botulinum toxin, Bradykinesia, Brainstem, Bupropion, Case report, Case reports, Caudate, Caudate nucleus, Caudate nucleus atrophy, Cdas, Cell models, Cerebellar, Cerebellar ataxia, Cerebellar atrophy, Cerebellum, Cerebral palsy, Cervical, Chain activity, Chorea, Choreatic movements, Choreic, Choreic movements, Choreiform, Choreiform movements, Chromosome, Chronic haloperidol, Chronic treatment, Clinic, Clinical, Clinical assessment, Clinical characteristics, Clinical diagnosis, Clinical features, Clinical improvement, Clinical presentation, Clinical presentations, Clinical progression, Clinical scores, Clinical spectrum, Clinical symptoms, Clonazepam, Clozapine, Cognitive, Cognitive disturbances, Cognitive dysfunction, Cognitive impairment, Coherence, Coherence analysis, Cohort, Coli, Comorbid, Comorbid symptoms, Compulsive disorder, Compulsive symptoms, Computerized tremor analysis, Concordance, Consecutive patients, Contralateral, Control group, Control groups, Control subjects, Cortical, Cortical myoclonus, Cortical tremor, Creatine, Crossover, Cyclooxygenase, Cyclooxygenase inhibitors, Deep tendon, Dementia, Diagnosis criteria, Diagnostic accuracy, Diagnostic criteria, Differential diagnosis, Disability, Disease duration, Disease duration years, Disease onset, Disease progression, Disease rating scale, Disease stage, Disorder, Dopamine, Dopaminergic, Dorsal, Dos, Dose, Drinking task, Drinking tremor, Drug intake, Dysarthria, Dysfunction, Dyskinesia, Dysmetria, Dystonia, Dystonic, Eds, Effective treatment, Electrical injury, Electromyography, Electrophysiological, Electrophysiological characteristics, Encephalopathy, Energy metabolism, Enhancement, Environmental factors, Epilepsia partialis continua, Epilepsy, Essential tremor, Etiology, Exam, Exor, Explosive outbursts, Extrapyramidal, Extrapyramidal symptoms, Facilitation, Familial, Familial cases, Family history, Frda, Functional disability, Further study, Gait, Gait analysis, Gait ataxia, Gait disturbance, Gait parameters, Ganglion, Gender, Gene, Genetic, Genetic analysis, Genetic factors, Genetic heterogeneity, Genetic testing, Globus, Globus pallidus, Glucose, Glutamate, Glutathione levels, Gluten, Gluten sensitivity, Graft, Gravitational acceleration, Haloperidol, Hand tremor, Harmane, Head tremor, Healthy controls, Healthy subjects, Hemichorea, Hemifacial spasm, Hereditary, Hereditary ataxias, Heterogeneous disorder, Heterogeneous group, Huntingtin, Hyperactivity, Hyperglycemia, Hyperintense, Hypometabolic voxels, Icars, Icars scores, Idiopathic, Imaging, Impairment, Implantation, Important role, Infarction, Inhibitor, Intention tremor, Interim analysis, International congress, Intrathecal, Intrathecal baclofen, Intrathecal baclofen therapy, Involuntary, Involuntary movements, Ipsilateral thalamic infarction, Ischemic, Jerk, Kinetic components, Latency, Lesion, Levetiracetam, Levodopa, Limb, Limb myoclonus, Linkage analysis, Lipid peroxidation, Locus, Lower doses, Lower limbs, Lumbar puncture, Magnetic resonance spectroscopy, Major depression, Male patient, Male patients, Matter changes, Median, Medication, Metabolism, Methamphetamine, Methylphenidate, Mirtazapine, Mitochondrial, Mitochondrial dysfunction, Monoclonal gammopathy, More subjects, Motor cortex, Motor effects, Motor performance, Motor score, Motor tics, Mouse model, Movement disorder, Movement disorders, Movement disorders clinic, Movement duration, Multiple motor, Multiple sclerosis, Muscle strength, Mutant, Mutant huntingtin, Mutation, Myoclonic, Myoclonic dystonia, Myoclonic jerks, Myoclonus, Nding, Ndings, Ndings support, Negative correlation, Neural network, Neurodegenerative, Neuroimaging, Neuroimaging studies, Neurol, Neuroleptic, Neurologic, Neurological, Neurological examination, Neurologist, Neurology, Neuron, Neuronal, Neuropathy, Neurophysiological, Neurophysiological examination, Neuropsychological, Neuropsychological testing, Neuropsychological tests, Nger, Nger test, Normal controls, Normal subjects, November, Nystagmus, Obsessive, Ocular, Ocular motor apraxia, Olanzapine, Olanzapine treatment, Older patients, Olmsted county, Open label, Opioid, Orobuccal dyskinesia, Orofacial, Orofacial dyskinesia, Orofacial dyskinesias, Orthostatic, Orthostatic tremor, Other medications, Other movement disorders, Other patients, Other signs, Oxidative, Oxidative stress, Palatal, Palatal tremor, Palsy, Paraneoplastic, Paraneoplastic syndrome, Parkinsonian, Parkinsonian patients, Parkinsonism, Pathogenesis, Pathophysiology, Pathway, Patient, Patient effort, Peripheral neuropathy, Peripheral origin, Pharmacological, Pharmacological treatment, Phenotype, Phonic, Phonic tics, Physiologic tremor, Piracetam, Placebo, Positive family history, Poster, Poster session, Postural, Postural conditions, Postural tremor, Premonitory, Premonitory sensation, Premonitory sensations, Present case, Present study, Prevalence, Previous reports, Previous studies, Primary orthostatic tremor, Progression, Progressive ataxia, Propranolol, Propriospinal, Propriospinal myoclonus, Pshd patients, Psychogenic, Putamen, Quantitative method, Quercetin, Randomized, Range years, Rating, Rating scale, Receptor, Receptor dysfunction, Refractory, Rest tremor, Restless legs syndrome, Retrospective chart review, Reversible chorea, Right putamen, Riluzole, Sarcoglycan gene, Sarizotan, Sca2, Sca2 patients, Schizophrenia, Sclerosis, Sensorimotor, Serotonin, Severe spasticity, Severe tremor, Severity, Severity scale, Sgce, Side effects, Single doses, Skeletal muscle, Spastic, Spastic hemiplegic patients, Spastic patients, Spastic side, Spasticity, Spect, Spectral analysis, Spinal, Spinal myoclonus, Spinocerebellar, Spirograph, Sporadic cases, Ssri, Statistical analysis, Stereotyped movement disorder, Stimulation, Striatal, Striatum, Study group, Study period, Subacute, Suppl, Symptom, Symptomatic palatal tremor, Synaptic, Syndrome, Tardive, Tardive dyskinesia, Test stimulation, Thalamic, Thalamus, Tic, Time points, Tizanidine, Tolerability, Tongue protrusions, Topiramate, Total power, Tourette, Tourette syndrome, Toxin, Tracer uptake, Transgenic mice, Trauma, Treatment periods, Treatment response, Tremor, Tremor accelerometry, Tremor amplitude, Tremor disability, Tremor disability scale, Tremor frequencies, Tremor frequency, Tremor rating scale, Tremor severity, Twin pairs, Uhdrs, Unclear, Upper limb, Useful tool, Utter syndrome, Valproic acid, Variability, Vocal tics, Voice tremor, Voluntary control, Voluntary motor function, Wide range, Wilcoxon test, Younger patients, Ziprasidone.

Url:

• https://api.istex.fr/document/62F90CE7D724C99CA696F9CEF306833784E60804/fulltext/pdf

DOI: 10.1002/mds.10355

Affiliations:

---

Links toward previous steps (curation, corpus...)

• to stream Istex, to step Corpus: 003076
• to stream Istex, to step Curation: 003076
• to stream Istex, to step Checkpoint: 003816
• to stream Main, to step Merge: 008700
• to stream Main, to step Curation: 008424

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008424 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008424 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:62F90CE7D724C99CA696F9CEF306833784E60804
   |texte=   Poster session 7: Ataxia, chorea, drug‐induced movement disorders, myoclonus, spasticity, stereotypies, tics, tremor
}}

---

This area was generated with Dilib version V0.6.32. Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022